Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of oral silymarin on memory in patients with dementia
IRCT201505091856N5Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of silymarin in Alzheimer's disease (AD), vascular dementia and Dementia, sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Change in memory status. Started May 2015; status: completed.
02
Drugs
silymarin
03
Conditions
Alzheimer's disease (AD)vascular dementiaDementia
Beyond the preview
Go deeper on IRCT201505091856N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201505091856N5.